(Q30979820)

English

Rosiglitazone treatment increases nitric oxide production in human peripheral skin: a controlled clinical trial in patients with type 2 diabetes mellitus

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Rosiglitazone treatment increases nitric oxide production in human peripheral skin: a controlled clinical trial in patients with type 2 diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

author name string

Aaron I Vinik

1

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Kevin B Stansberry

2

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Patricia M Barlow

3

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Journal of Diabetes and its Complications

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

279-285

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Insulin resistance and vascular function

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic exercise is associated with enhanced cutaneous blood flow in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure, sodium intake, insulin resistance, and urinary nitrate excretion

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Nitrosative stress, uric Acid, and peripheral nerve function in early type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced microvascular hyperaemia in subjects at risk of developing type 2 (non-insulin-dependent) diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Skin microvascular vasodilatory capacity in offspring of two parents with Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects. Relationship to microvascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of nitric oxide synthase inhibition on cutaneous vasodilation during body heating in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes: a new model for the pathogenesis of microvascular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Dermal neurovascular dysfunction in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular protective effects by activation of nuclear receptor PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2803%2900006-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1056-8727(03)00006-0

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30979820&oldid=1546320241"